{"filing":{"accession_number":"0001731122-26-001000","cik":"0001314052","ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","form":"8-K","filing_date":"2026-08-03","report_date":"2026-08-03","primary_document":"e7823_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226001000/e7823_8-k.htm"},"events":[{"id":23459,"run_id":21209,"accession_number":"0001731122-26-001000","anchor_item_number":"7.01","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"This disclosure announces a board refresh with nomination of two new independent directors (Gautam Patel and Adrian Senderowicz) and non-reelection of two existing directors (Christopher Missling and Steffen Thomas) at the 2026 Annual Meeting, in response to a proxy contest by PVG Asset Management. While the filing involves shareholder voting, the core event is a governance restructuring—board composition changes and leadership transitions—rather than a shareholder vote result. The disclosure is material as it affects board composition and control, but does not fit the specific `shareholder_vote_results` category (which applies to vote outcomes, not pre-vote nominations).","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-08-03","form":"8-K","submitted_at":null,"items":[{"id":23688,"accession_number":"0001731122-26-001000","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure announces a board refresh with nomination of two new independent directors (Gautam Patel and Adrian Senderowicz) and non-reelection of two existing directors (Christopher Missling and Steffen Thomas) at the 2026 Annual Meeting, in response to a proxy contest by PVG Asset Management. While the filing involves shareholder voting, the core event is a governance restructuring—board composition changes and leadership transitions—rather than a shareholder vote result. The disclosure is material as it affects board composition and control, but does not fit the specific `shareholder_vote_results` category (which applies to vote outcomes, not pre-vote nominations).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:33:43.457846+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23688,"accession_number":"0001731122-26-001000","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure announces a board refresh with nomination of two new independent directors (Gautam Patel and Adrian Senderowicz) and non-reelection of two existing directors (Christopher Missling and Steffen Thomas) at the 2026 Annual Meeting, in response to a proxy contest by PVG Asset Management. While the filing involves shareholder voting, the core event is a governance restructuring—board composition changes and leadership transitions—rather than a shareholder vote result. The disclosure is material as it affects board composition and control, but does not fit the specific `shareholder_vote_results` category (which applies to vote outcomes, not pre-vote nominations).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:33:43.457846+00:00","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-08-03"}]}